Rowlens M Melduni1, Hartzell V Schaff2, Hon-Chi Lee2, Bernard J Gersh2, Peter A Noseworthy2, Kent R Bailey2, Naser M Ammash2, Stephen S Cha2, Kaniz Fatema2, Waldemar E Wysokinski2, James B Seward2, Douglas L Packer2, Charanjit S Rihal2, Samuel J Asirvatham2. 1. From Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN (R.M.M., H.-C.L., B.J.G., P.A.N., N.M.A., K.F., W.E.W., J.B.S., D.L.P., C.S.R., S.J.A.); Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN (H.V.S.); and Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN (K.R.B., S.S.C.). melduni.rowlens@mayo.edu. 2. From Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN (R.M.M., H.-C.L., B.J.G., P.A.N., N.M.A., K.F., W.E.W., J.B.S., D.L.P., C.S.R., S.J.A.); Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN (H.V.S.); and Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN (K.R.B., S.S.C.).
Abstract
BACKGROUND: Prophylactic exclusion of the left atrial appendage (LAA) is often performed during cardiac surgery ostensibly to reduce the risk of stroke. However, the clinical impact of LAA closure in humans remains inconclusive. METHODS: Of 10 633 adults who underwent coronary artery bypass grafting and valve surgery between January 2000 and December 2005, 9792 patients with complete baseline characteristics, surgery procedure, and follow-up data were included in this analysis. A propensity score-matching analysis based on 28 pretreatment covariates was performed and 461 matching pairs were derived and analyzed to estimate the association of LAA closure with early postoperative atrial fibrillation (POAF) (atrial fibrillation ≤30 days of surgery), ischemic stroke, and mortality. RESULTS: In the propensity-matched cohort, the overall incidence of POAF was 53.9%. In this group, the rate of early POAF among the patients who underwent LAA closure was 68.6% versus 31.9% for those who did not undergo the procedure (P<0.001). LAA closure was independently associated with an increased risk of early POAF (adjusted odds ratio, 3.88; 95% confidence interval, 2.89-5.20), but did not significantly influence the risk of stroke (adjusted hazard ratio, 1.07; 95% confidence interval, 0.72-1.58) or mortality (adjusted hazard ratio, 0.92; 95% confidence interval, 0.75-1.13). CONCLUSIONS: After adjustment for treatment allocation bias, LAA closure during routine cardiac surgery was significantly associated with an increased risk of early POAF, but it did not influence the risk of stroke or mortality. It remains uncertain whether prophylactic exclusion of the LAA is warranted for stroke prevention during non-atrial fibrillation-related cardiac surgery.
BACKGROUND: Prophylactic exclusion of the left atrial appendage (LAA) is often performed during cardiac surgery ostensibly to reduce the risk of stroke. However, the clinical impact of LAA closure in humans remains inconclusive. METHODS: Of 10 633 adults who underwent coronary artery bypass grafting and valve surgery between January 2000 and December 2005, 9792 patients with complete baseline characteristics, surgery procedure, and follow-up data were included in this analysis. A propensity score-matching analysis based on 28 pretreatment covariates was performed and 461 matching pairs were derived and analyzed to estimate the association of LAA closure with early postoperative atrial fibrillation (POAF) (atrial fibrillation ≤30 days of surgery), ischemic stroke, and mortality. RESULTS: In the propensity-matched cohort, the overall incidence of POAF was 53.9%. In this group, the rate of early POAF among the patients who underwent LAA closure was 68.6% versus 31.9% for those who did not undergo the procedure (P<0.001). LAA closure was independently associated with an increased risk of early POAF (adjusted odds ratio, 3.88; 95% confidence interval, 2.89-5.20), but did not significantly influence the risk of stroke (adjusted hazard ratio, 1.07; 95% confidence interval, 0.72-1.58) or mortality (adjusted hazard ratio, 0.92; 95% confidence interval, 0.75-1.13). CONCLUSIONS: After adjustment for treatment allocation bias, LAA closure during routine cardiac surgery was significantly associated with an increased risk of early POAF, but it did not influence the risk of stroke or mortality. It remains uncertain whether prophylactic exclusion of the LAA is warranted for stroke prevention during non-atrial fibrillation-related cardiac surgery.
Authors: E S Katz; T Tsiamtsiouris; R M Applebaum; A Schwartzbard; P A Tunick; I Kronzon Journal: J Am Coll Cardiol Date: 2000-08 Impact factor: 24.094
Authors: M Ruiz Ortiz; E Romo Peñas; M F Franco Zapata; D Mesa Rubio; M Anguita Sánchez; A López Granados; J M Arizón del Prado; F Vallés Belsué Journal: Heart Date: 2005-09 Impact factor: 5.994
Authors: T Tabata; T Oki; H Yamada; A Iuchi; S Ito; T Hori; T Kitagawa; I Kato; H Kitahata; S Oshita Journal: Am J Cardiol Date: 1998-02-01 Impact factor: 2.778
Authors: Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy Journal: Circulation Date: 2014-03-28 Impact factor: 29.690
Authors: Daniel J Friedman; Jonathan P Piccini; Tongrong Wang; Jiayin Zheng; S Chris Malaisrie; David R Holmes; Rakesh M Suri; Michael J Mack; Vinay Badhwar; Jeffrey P Jacobs; Jeffrey G Gaca; Shein-Chung Chow; Eric D Peterson; J Matthew Brennan Journal: JAMA Date: 2018-01-23 Impact factor: 56.272
Authors: Etem Caliskan; James L Cox; David R Holmes; Bernhard Meier; Dhanunjaya R Lakkireddy; Volkmar Falk; Sacha P Salzberg; Maximilian Y Emmert Journal: Nat Rev Cardiol Date: 2017-08-10 Impact factor: 32.419
Authors: Jurij M Kalisnik; Giuseppe Santarpino; Andrea I Balbierer; Janez Zibert; Ferdinand A Vogt; Matthias Fittkau; Theodor Fischlein Journal: J Clin Med Date: 2022-06-14 Impact factor: 4.964
Authors: Daniel O Johnsrud; Rowlens M Melduni; Brian Lahr; Xiaoxi Yao; Kevin L Greason; Peter A Noseworthy Journal: Clin Cardiol Date: 2018-12-10 Impact factor: 2.882
Authors: W E Wysokinski; K P Cohoon; R M Melduni; M Mazur; N Ammash; T Munger; E Konik; T McLeod; Izabeal Gosk-Bierska; R D McBane Journal: Thromb Res Date: 2018-10-10 Impact factor: 3.944